Stockscreener 앱 받기
14.55
0.65%
-0.095
시간 외 거래:
14.23
-0.325
-2.23%
Keros Therapeutics Inc 주식(KROS)의 최신 뉴스
(KROS) Long Term Investment Analysis - news.stocktradersdaily.com
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Sold by Alkeon Capital Management LLC - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Acquired by Barclays PLC - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Stock Position Lifted by Emerald Mutual Fund Advisers Trust - MarketBeat
Boxer Capital Management LLC Purchases New Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Tower Research Capital LLC TRC Acquires 21,145 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
TCG Crossover Management LLC Trims Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Darwin Global Management Ltd. Grows Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Nebula Research & Development LLC Has $1.14 Million Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
544,001 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Acquired by Lynx1 Capital Management LP - MarketBeat
Keros Therapeutics Inc expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Was Keros Therapeutics Inc (KROS)’s session last reading good? - uspostnews.com
Implied Volatility Surging for Keros Therapeutics Stock Options - Yahoo Finance
Keros Therapeutics Inc [KROS] 10% Owner makes an insider purchase of 934,258 shares worth 9.46 million. - knoxdaily.com
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Purchased by Blue Owl Capital Holdings LP - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Sold by Russell Investments Group Ltd. - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Geode Capital Management LLC Boosts Position in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) PT at $40.33 - Defense World
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Bought by Altium Capital Management LLC - MarketBeat
197,666 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Bought by Walleye Capital LLC - MarketBeat
Alliancebernstein L.P. Decreases Stake in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
JPMorgan Chase & Co. Acquires 182,314 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World
Keros Therapeutics, Inc. (NASDAQ:KROS) Major Shareholder Purchases $9,464,033.54 in Stock - MarketBeat
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Bought by Vanguard Group Inc. - MarketBeat
How the (KROS) price action is used to our Advantage - news.stocktradersdaily.com
Keros Therapeutics enters agreement with Pontifax By Investing.com - Investing.com India
124,620 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Acquired by Federated Hermes Inc. - MarketBeat
Keros Therapeutics enters agreement with Pontifax - Investing.com Australia
Norges Bank Invests $1.03 Million in Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat
0.39%
3.66%
자본화:
|
볼륨(24시간):